← Leaderboards
Rebecca H Buckley
Duke University
$9,502,389
Attributed
$9,502,389
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–13$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$9,502,389 · 7
By mechanism
R01$5,646,554 · 2
M01$2,539,667 · 2
T32$599,016 · 1
U54$373,727 · 1
R21$343,425 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Jason Randall Rock$5,832,852
- Daniel B Mark$29,174,449
- Vijay Krishnamoorthy$1,534,883
- L Darryl Quarles$19,109,320
- Mary H Foster$6,787,316
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchSevere Combined ImmunodeficiencyHuman Therapy EvaluationBone Marrow TransplantationTissue MosaicismNatural Killer CellsLymphocyteChild (0-11)CytokineVirus DiseasesT LymphocyteB LymphocyteClinical TrialsCellsMarrowLifeCell PhysiologyReconstitutionInfantCell CountImmunogeneticsImmuneGraft-Vs-Host Disease
Grant awards (40)
Prospective Study of SCID Infants Who Receive Hematopoietic Cell Therapy$75,050
U54 · FY2013 · AI · contact PI
Prospective Study of SCID Infants Who Receive Hematopoietic Cell Therapy$119,405
U54 · FY2012 · AI · contact PI
Prospective Study of SCID Infants Who Receive Hematopoietic Cell Therapy$179,272
U54 · FY2011 · AI · contact PI
Mechanisms of Allogeneic Stem Cell Education in SCID$390,000
R01 · FY2010 · AI · contact PI
Mechanisms of Allogeneic Stem Cell Education in SCID$390,000
R01 · FY2009 · AI · contact PI
Mechanisms of Allogeneic Stem Cell Education in SCID$322,304
R01 · FY2008 · AI · contact PI
Development And Persistence Of Immunity In SCID Chimeras$322,302
R01 · FY2008 · AI · contact PI
Development And Persistence Of Immunity In SCID Chimeras$328,545
R01 · FY2007 · AI · contact PI
Mechanisms of Allogeneic Stem Cell Education in SCID$328,545
R01 · FY2007 · AI · contact PI
Development And Persistence Of Immunity In SCID Chimeras$338,358
R01 · FY2006 · AI · contact PI
Mechanisms of Allogeneic Stem Cell Education in SCID$338,358
R01 · FY2006 · AI · contact PI
GENETICALLY-DETERMINED IMMUNODEFICIENCIES: ANALYSES OF DEFECTS AND THERAPIES$437,782
M01 · FY2005 · RR
Development And Persistence Of Immunity In SCID Chimeras$346,500
R01 · FY2005 · AI
Mechanisms of Allogeneic Stem Cell Education in SCID$343,425
R01 · FY2005 · AI
Genetically-Determined Immunodeficiencies$772,708
M01 · FY2004 · RR
Development And Persistence Of Immunity In SCID Chimeras$346,500
R01 · FY2004 · AI
Mechanisms of Allogeneic Stem Cell Education in SCID$343,425
R21 · FY2003 · AI
DEVELOPMENT AND PERSISTENCE OF IMMUNITY IN SCID CHIMERAS$263,281
R01 · FY2003 · AI
RESEARCH TRAINING IN ALLERGY AND CLINICAL IMMUNOLOGY$163,757
T32 · FY2003 · AI
MECHANISMS OF ALLOGENEIC STEM CELL EDUCATION IN SCID$288,688
R01 · FY2002 · AI
DEVELOPMENT AND PERSISTENCE OF IMMUNITY IN SCID CHIMERAS$255,615
R01 · FY2002 · AI
RESEARCH TRAINING IN ALLERGY AND CLINICAL IMMUNOLOGY$157,835
T32 · FY2002 · AI
GENETICALLY DETERMINED IMMUNODEFICIENCIES--ANALYSES OF DEFECTS AND THERAPIES$117,022
M01 · FY2002 · RR
PH I: IGIV CHROMATOGRAPHY, 10% VS IGIV SOLVENT DETERGENT TREATED 10%$117,022
M01 · FY2002 · RR
GENETICALLY DETERMINED IMMUNODEFICIENCIES--ANALYSES OF DEFECTS AND THERAPIES$293,069
M01 · FY2001 · RR
PH I: IGIV CHROMATOGRAPHY, 10% VS IGIV SOLVENT DETERGENT TREATED 10%$293,069
M01 · FY2001 · RR
MECHANISMS OF ALLOGENEIC STEM CELL EDUCATION IN SCID$281,611
R01 · FY2001 · AI
DEVELOPMENT AND PERSISTENCE OF IMMUNITY IN SCID CHIMERAS$248,173
R01 · FY2001 · AI
RESEARCH TRAINING IN ALLERGY AND CLINICAL IMMUNOLOGY$144,236
T32 · FY2001 · AI
PH I: IGIV CHROMATOGRAPHY, 10% VS IGIV SOLVENT DETERGENT TREATED 10%$117,022
M01 · FY2001 · RR
PH I: IGIV CHROMATOGRAPHY, 10% VS IGIV SOLVENT DETERGENT TREATED 10%$117,022
M01 · FY2001 · RR
GENETICALLY DETERMINED IMMUNODEFICIENCIES--ANALYSES OF DEFECTS AND THERAPIES$117,022
M01 · FY2001 · RR
GENETICALLY DETERMINED IMMUNODEFICIENCIES--ANALYSES OF DEFECTS AND THERAPIES$117,022
M01 · FY2001 · RR
MECHANISMS OF ALLOGENEIC STEM CELL EDUCATION IN SCID$273,407
R01 · FY2000 · AI
DEVELOPMENT AND PERSISTENCE OF IMMUNITY IN SCID CHIMERAS$240,942
R01 · FY2000 · AI
RESEARCH TRAINING IN ALLERGY AND CLINICAL IMMUNOLOGY$133,188
T32 · FY2000 · AI
PH I: IGIV CHROMATOGRAPHY, 10% VS IGIV SOLVENT DETERGENT TREATED 10%$40,907
M01 · FY2000 · RR
GENETICALLY DETERMINED IMMUNODEFICIENCIES--ANALYSES OF DEFECTS AND THERAPIES$0
M01 · FY2000 · RR
PH I: IGIV CHROMATOGRAPHY, 10% VS IGIV SOLVENT DETERGENT TREATED 10%$0
M01 · FY2000 · RR
GENETICALLY DETERMINED IMMUNODEFICIENCIES--ANALYSES OF DEFECTS AND THERAPIES$0
M01 · FY2000 · RR